![Quiver Logo](/static/img/logo-icon.png)
![CELU logo](https://quiver-logos.s3.us-east-2.amazonaws.com/celu.png)
Celularity Inc. Class A Common Stock
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view CELU Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Recent trades of CELU by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by CELU's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to CELU
Recent picks made for CELU stock on CNBC
ETFs with the largest estimated holdings in CELU
Flights by private jets registered to CELU
![Quiver Logo](/static/img/logo-icon.png)